- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
Is SoundHound AI Stock a Bargain After the 50% Crash? The Pros and Cons.
SoundHound AI is an intriguing company that’s immersed in a niche AI-tech market, but don’t overload your portfolio with SoundHound AI stock.
Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
Neumora Therapeutics stock is falling on Monday as investors in NMRA shares react to a clinical trial being put on hold by the FDA.
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.
A Healthy Dose of Reality
Every now and then my hometown team, the Seattle Mariners, and the shares of large companies behave similarly. Volume has been light as the market…
GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q4 2023
GVP stock results show that GSE Systems beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Monday’s Apple Rumors: A ‘Daily’ Dose
The company’s daily newspaper collaboration with News Corp. looks to be on track for a mid-January release.
XLV Provides a Healthy Dose of Pfizer
If the health care sector is a must-have for your portfolio, and Pfizer is at the top of that list — here’s a way to…
Get a Dose of Innovative Science With Mind Medicine
MNMD stock ran high last year, but the story is still being written as Mind Medicine marks progress with its psychedelics-based treatments.
Wall Street Slapped With a Cold Dose of Reality
Stocks suffered their worst day in months Thursday as North Korean headlines continued to weigh on the Dow. What to watch for now? Market breadth.
Trade of the Day: Real Goods Solar (RGSE)
Colorado-based Real Goods Solar (RGSE) flashed as a potential bullish play in the solar space.
For Biopharma Ocugen, Think Speculation In Small Doses
While Ocugen is unprofitable and in bad need of cash, OCGN stock could soar if its eye disease therapies see clinical success.
Dish Bids for Sprint But Needs Dose of Reality
Charlie Ergen — CEO of Dish Network — is taking a huge gamble with his recent unsolicited bid for Sprint, as the deal only sounds…
Why Is Stoke Therapeutics (STOK) Stock Up 99% Today?
Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.
Upstart Stock Is Getting a Dose of Reality With Another Downgrade
UPST stock is proving very volatile as analysts sour on its prospects and pile on with price downgrades as the economy shifts.
Microsoft (MSFT) Offers a Double Dose of Good News
Microsoft has announced board changes as well as a dividend increase.
Zynga’s Job Cuts Another Sobering Dose of Reality
Zynga is cutting 520 jobs and closing three offices as the company’s user numbers continue to disappoint.
JPMorgan Earnings Preview — Expect a Hard Dose of Reality
Investors expect ugly earnings and a subsequent drop in stock, and they’ll probably get it — but JPMorgan could do some good with its report.
Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.
3 – 10 of 240 results
